Yijing He

4.2k total citations · 1 hit paper
138 papers, 2.9k citations indexed

About

Yijing He is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Yijing He has authored 138 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 31 papers in Oncology and 24 papers in Pharmacology. Recurrent topics in Yijing He's work include Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (11 papers). Yijing He is often cited by papers focused on Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (15 papers) and Cancer, Stress, Anesthesia, and Immune Response (11 papers). Yijing He collaborates with scholars based in China, United States and United Kingdom. Yijing He's co-authors include Howard L. McLeod, Lan Fan, Wei Zhang, Zhaoqian Liu, Hong‐Hao Zhou, Zhi‐Rong Tan, Yuanfei Huang, Qing Li, Daqing Wang and Wolfgang Sadée and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Analytical Chemistry.

In The Last Decade

Yijing He

127 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing

2015 499 citations Kelly A. Birdwell, Brian S. Decker et al. Clinical Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yijing He China	27	798	724	692	617	343	138	2.9k
Atsushi Yonezawa Japan	30	1.6k 2.0×	1.1k 1.5×	243 0.4×	830 1.3×	150 0.4×	126	3.8k
Michel Lemaire Japan	28	952 1.2×	619 0.9×	279 0.4×	699 1.1×	319 0.9×	62	2.4k
Ganesan Ramesh United States	37	693 0.9×	2.1k 2.9×	289 0.4×	532 0.9×	47 0.1×	66	6.4k
Robert Safirstein United States	42	986 1.2×	2.5k 3.5×	255 0.4×	485 0.8×	68 0.2×	89	5.9k
Judit Megyesi United States	36	609 0.8×	1.8k 2.5×	167 0.2×	267 0.4×	60 0.2×	69	4.1k
Robert Schmouder United States	32	520 0.7×	2.2k 3.1×	215 0.3×	268 0.4×	1.3k 3.8×	93	5.4k
Akihiro Tojo Japan	45	814 1.0×	1.5k 2.1×	188 0.3×	614 1.0×	24 0.1×	141	5.9k
Nimesh S. A. Patel United Kingdom	41	457 0.6×	1.5k 2.1×	113 0.2×	128 0.2×	85 0.2×	84	4.6k
Diego Rodrı́guez-Puyol Spain	37	247 0.3×	1.5k 2.1×	74 0.1×	291 0.5×	73 0.2×	172	4.6k
Birgitta C. Burckhardt Germany	24	666 0.8×	1.0k 1.4×	109 0.2×	268 0.4×	37 0.1×	52	2.2k

Countries citing papers authored by Yijing He

Since Specialization

Citations

This map shows the geographic impact of Yijing He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijing He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijing He more than expected).

Fields of papers citing papers by Yijing He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijing He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijing He. The network helps show where Yijing He may publish in the future.

Co-authorship network of co-authors of Yijing He

This figure shows the co-authorship network connecting the top 25 collaborators of Yijing He. A scholar is included among the top collaborators of Yijing He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijing He. Yijing He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Yu, Feng Yu, Jing Ouyang, et al.. (2025). ADRB2 inhibition suppresses cancer immune evasion by regulating tumor SOX10-PD-L1 axis and T cell function. Journal for ImmunoTherapy of Cancer. 13(6). e011611–e011611. 2 indexed citations

Feng, Yu‐Qi, et al.. (2025). Metaproteomics of human microbiota: Progress and key challenges for precision medicine. Process Biochemistry. 156. 59–75. 1 indexed citations

Liu, Yanhong, Yijing He, Qinfeng Sun, et al.. (2025). Alpha-Tocopherol Protects Porcine Oocytes from Acetamiprid-Induced Meiotic Defects by Alleviating Oxidative Stress-Mediated Ferroptosis. Antioxidants. 14(11). 1304–1304.

He, Yijing, Heran Li, Qinfeng Sun, et al.. (2024). Polystyrene nanoplastic exposure actives ferroptosis by oxidative stress-induced lipid peroxidation in porcine oocytes during maturation. Journal of Animal Science and Biotechnology. 15(1). 117–117. 19 indexed citations

Zheng, Juyan, Tao Zhu, Wei Zhuo, et al.. (2023). eIF3a sustains non-small cell lung cancer stem cell-like properties by promoting YY1-mediated transcriptional activation of β-catenin. Biochemical Pharmacology. 213. 115616–115616. 9 indexed citations

Wen, Wen, et al.. (2023). Embodied industrial PM2.5-related health impact flows and economic benefits of the Belt and Road Initiative towards China. Journal of Cleaner Production. 395. 136365–136365. 2 indexed citations

Lü, Peng, Yijing He, Lifang Zhang, et al.. (2023). Apolipoprotein E Polymorphism Impacts White Matter Injury Through Microglial Phagocytosis After Experimental Subarachnoid Hemorrhage. Neuroscience. 524. 220–232. 4 indexed citations

Zhang, Lihan, Yijing He, Long Gu, et al.. (2023). TRPM4 Drives Cerebral Edema by Switching to Alternative Splicing Isoform After Experimental Traumatic Brain Injury. Journal of Neurotrauma. 40(15-16). 1779–1795. 2 indexed citations

Luo, Jia, Ling Chen, Wenjuan Ma, et al.. (2022). PARPi treatment enhances radiotherapy-induced ferroptosis and antitumor immune responses via the cGAS signaling pathway in colorectal cancer. Cancer Letters. 550. 215919–215919. 58 indexed citations

10.

Li, Wei, Chengfang Zhou, Ping Liao, et al.. (2022). Dissecting the role of cell signaling versus CD8+ T cell modulation in propranolol antitumor activity. Journal of Molecular Medicine. 100(9). 1299–1306. 11 indexed citations

11.

Xia, Tong, Hui Lei, Yijing He, et al.. (2022). Identification of an ergosterol derivative with anti-melanoma effect from the sponge-derived fungus Pestalotiopsis sp. XWS03F09. Frontiers in Microbiology. 13. 1008053–1008053. 5 indexed citations

12.

Yang, Mengying, Honglei Wang, Changyan Chen, et al.. (2021). Glia-derived temporal signals orchestrate neurogenesis in the Drosophila mushroom body. Proceedings of the National Academy of Sciences. 118(23). 5 indexed citations

13.

Hu, Jiali, Yu Zhang, Wei Li, et al.. (2021). β-adrenergic receptor inhibition enhances oncolytic herpes virus propagation through STAT3 activation in gastric cancer. Cell & Bioscience. 11(1). 174–174. 8 indexed citations

14.

Liao, Ping, Kun Song, Zhaoqian Liu, et al.. (2020). Propranolol Suppresses the Growth of Colorectal Cancer Through Simultaneously Activating Autologous CD8⁺ T Cells and Inhibiting Tumor AKT/MAPK Pathway. Clinical Pharmacology & Therapeutics. 108(3). 606–615. 33 indexed citations

15.

Birdwell, Kelly A., Brian S. Decker, Julia M. Barbarino, et al.. (2015). Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing. Data Archiving and Networked Services (DANS). 63 indexed citations

16.

Shu, Yan, Qing Li, Linyong Xu, et al.. (2013). Polymorphism of ORM1 Is Associated with the Pharmacokinetics of Telmisartan. PLoS ONE. 8(8). e70341–e70341. 12 indexed citations

17.

Zeng, Yun‐Yun, et al.. (2009). Effect of bifendate on the pharmacokinetics of talinolol in healthy subjects. Xenobiotica. 39(11). 844–849. 1 indexed citations

18.

Chen, Bi‐Lian, Wei Zhang, Qing Li, et al.. (2008). INHIBITION OF ADP‐INDUCED PLATELET AGGREGATION BY CLOPIDOGREL IS RELATED TOCYP2C19GENETIC POLYMORPHISMS. Clinical and Experimental Pharmacology and Physiology. 35(8). 904–908. 22 indexed citations

19.

Zhang, Wei, Bi‐Lian Chen, Vural Özdemir, et al.. (2007). SLCO1B1 521T→C functional genetic polymorphism and lipid‐lowering efficacy of multiple‐dose pravastatin in Chinese coronary heart disease patients. British Journal of Clinical Pharmacology. 64(3). 346–352. 58 indexed citations

20.

Liu, Yali, Wei Zhang, Zhi‐Rong Tan, et al.. (2005). Effect of the CYP2C9*3 allele on lornoxicam metabolism. Clinica Chimica Acta. 364(1-2). 287–291. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact